Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how professional tools and equipment stocks fared in Q1, starting with Nordson (NASDAQ:NDSN).
Vanguard's quietest fund is quietly outperforming its most popular one, and the reason comes down to a style bet most investors never realized they were making.
Pure-play EV stocks are surging past their legacy rivals Wednesday, but no earnings beat or product launch explains the move. The real catalyst traces back to a quiet Treasury Department announcement that rattled the bond market.
Dell Technologies (NYSE:DELL) gaming brand Alienware and Team Liquid announced a five year extension of their esports partnership. The renewed agreement expands beyond hardware sponsorship into co-development of high performance peripherals and esports infrastructure. The partnership focuses on consistent performance and global facilities that support Team Liquid athletes and content operations. Both brands position the alliance as a long term platform for product R&D within the global...
Rigetti Computing, Inc. reported its second-quarter 2026 results, with sales rising to US$5.14 million from US$1.80 million a year earlier while net loss increased to US$52.61 million from US$39.65 million, alongside a U.S. Department of Commerce letter of intent for up to US$100.00 million in quantum R&D support. The combination of rapid revenue growth, deeper U.S. government engagement, and new commercial system deliveries with partners such as Nvidia and HPE highlights Rigetti’s growing...
Estee Lauder (EL) shares rallied Wednesday after the cosmetics maker bumped up its fiscal 2027 opera
Tesla's stock is on track for its worst performance since 2022, but back then, the markets as a whole were struggling.
Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.
Hinge Health's nearly 90% YTD surge is backed by 53% revenue growth, wider margins and expansion into migraine and GI care, but execution risks remain.
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
Wedbush sees another sign of memory inflation.
Bitcoin broke above $68,000 Wednesday, lifting shares of many crypto stocks as digital-currency leaders are scheduled to meet with President Trump in the White House this afternoon. The largest cryptocurrency gained about 6% and recently traded around $68,500, its largest percentage increase since March.
Applied Optoelectronics and Lumentum both benefit from AI-driven optical networking demand, but the latter's stronger growth and rising estimates give it the edge.
SNOW's AI adoption is growing rapidly, but Dell Technologies' stronger earnings momentum, AI server demand and diversified drivers may offer greater upside.
During the second quarter, Berkshire became a net buyer of stocks for the first time in over three years.
Devon Energy;s shares rise 9.2% in a month as its multi-basin portfolio, low-cost operations and modest leverage support growth amid commodity volatility.
Industrial stocks have gotten expensive, but here are some with the most attractive growth prospects.
OPKO Health pairs a discounted forward sales multiple with narrowing losses and partnership support, but early-stage clinical risk keeps the investment case balanced.
Bitcoin just broke above $68,000 for the first time in months, sparking a furious single-day surge across crypto equities, but the companies leading the charge are still nursing brutal year-to-date losses that raise the question of whether this rally signals a real turning point or just a violent short squeeze.
A decade of rewarding a simple monthly habit does not guarantee the next chapter follows the same script, and 2026 is already writing something different for SCHG investors. Where you sit in your personal timeline determines whether this year's numbers are a quiet gift or a warning worth acting on.
OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks.
Joby's eVTOL vision has never been closer to reality. Is it time to buy while the stock is still down?
Retail giant Walmart (NASDAQ:WMT) aims to silence growing analyst skepticism when it reports second-quarter financial results Thursday before market open. Here are the earnings estimates, what analysts are saying ahead of the report and key items to watch. Walmart Q2 Earnings Estimates Analysts expect Walmart to report second-quarter revenue of $186.8 billion, up from $177.4 billion in last year’s second quarter, according to data from Benzinga Pro. The company has beaten analyst estimates for r
A sharp move in the Treasury market sent fintech stocks surging at midday Wednesday, but the year-to-date scorecards for SoFi and Upstart tell a far more complicated story than a single rally can fix.
Bitcoin is surging, tokenized stocks are breaking records, and two retail brokerages are racing to claim the next era of American finance before regulators decide who gets left behind.
UNH's improving medical costs, higher EPS estimates and capital returns support its recovery, but regulatory risks remain.
NCLH's steep valuation discount faces a major test as falling earnings estimates, weak yields and high leverage cloud its recovery.
ANET is riding surging AI networking demand as Etherlink customers top 100 and diverse AI architectures expand its opportunity.
Can we count your visit with Google Analytics? No ads, no profiles. Details
